Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalling Bosse

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Journal for Immunotherapy of Cancer|September 5, 2019
High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 statusKim E Kortekaas, Saskia J Santegoets, Ziena Abdulrahman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 25, 2013
Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancerTjalling Bosse, Natalja T ter Haar, Laura M Seeber, et al.
Clinical Case Reports|September 8, 2017
A novel keratin 13 variant in a four-generation family with white sponge nevusStephanie B de Haseth, Egbert Bakker, Maarten H Vermeer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
Amplification of 1q32.1 Refines the Molecular Classification of Endometrial CarcinomaJeroen Depreeuw, Ellen Stelloo, Elisabeth M Osse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Adjuvant Treatment for <i>POLE</i> Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside AnaloguesInge C Van Gool, Emily Rayner, Elisabeth M Osse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic SignificanceLinda S Nooij, Natalja T Ter Haar, Dina Ruano, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 5, 2004
Complex regulation of the lactase-phlorizin hydrolase promoter by GATA-4Herbert M van Wering, Tjalling Bosse, Anna Musters, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2016
Exploring Morphologic and Molecular Aspects of Endometrial Cancer Under Progesterone Treatment in the Context of Fertility PreservationMignon D J M van Gent, Alina R Nicolae-Cristea, Cor D de Kroon, et al.
Cancers|July 2, 2021
The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor BlocksLise M van Wijk, Claire J H Kramer, Sylvia Vermeulen, et al.
Cancers|December 30, 2020
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical OutcomesLisa Vermij, Nanda Horeweg, Alicia Leon-Castillo, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Journal for Immunotherapy of Cancer|September 5, 2019
High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 statusKim E Kortekaas, Saskia J Santegoets, Ziena Abdulrahman, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 25, 2013
Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancerTjalling Bosse, Natalja T ter Haar, Laura M Seeber, et al.
Clinical Case Reports|September 8, 2017
A novel keratin 13 variant in a four-generation family with white sponge nevusStephanie B de Haseth, Egbert Bakker, Maarten H Vermeer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
Amplification of 1q32.1 Refines the Molecular Classification of Endometrial CarcinomaJeroen Depreeuw, Ellen Stelloo, Elisabeth M Osse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 22, 2018
Adjuvant Treatment for <i>POLE</i> Proofreading Domain-Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside AnaloguesInge C Van Gool, Emily Rayner, Elisabeth M Osse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
Genomic Characterization of Vulvar (Pre)cancers Identifies Distinct Molecular Subtypes with Prognostic SignificanceLinda S Nooij, Natalja T Ter Haar, Dina Ruano, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 5, 2004
Complex regulation of the lactase-phlorizin hydrolase promoter by GATA-4Herbert M van Wering, Tjalling Bosse, Anna Musters, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 31, 2016
Exploring Morphologic and Molecular Aspects of Endometrial Cancer Under Progesterone Treatment in the Context of Fertility PreservationMignon D J M van Gent, Alina R Nicolae-Cristea, Cor D de Kroon, et al.
Cancers|July 2, 2021
The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor BlocksLise M van Wijk, Claire J H Kramer, Sylvia Vermeulen, et al.
Cancers|December 30, 2020
HER2 Status in High-Risk Endometrial Cancers (PORTEC-3): Relationship with Histotype, Molecular Classification, and Clinical OutcomesLisa Vermij, Nanda Horeweg, Alicia Leon-Castillo, et al.
Pageof 17